Table 1.
Participant characteristics and bivariate analysis between hypertensive and normotensive PLWH, the Florida Cohort, October 2014 - December 2018.
| Variables | Total | Hypertensive | Normotensive | p-value |
|---|---|---|---|---|
| Total, n (%) | 659 | 266 (40.4) | 393 (69.6) | |
| Age, n (%) | <0.01 | |||
| 18–34 | 124 (19.3) | 23 (8.9) | 101 (26.3) | |
| 35–44 | 134 (20.9) | 44 (17.0) | 90 (23.4) | |
| 45–54 | 242 (37.7) | 107 (44.5) | 135 (35.2) | |
| ≥55 | 142 (22.1) | 84 (32.6) | 58 (15.1) | |
| Median (IQR) | 48 (38,54) | 51(45, 57) | 46 (35, 52) | <0.01 |
| Male, n (%) | 415 (64.6) | 144 (55.8) | 271 (70.6) | <0.01 |
| Race/ethnicity, n (%) | <0.01 | |||
| Hispanics | 95 (14.8) | 37 (14.3) | 58 (15.1) | |
| Whites | 140 (21.8) | 42 (16.3) | 98 (25.5) | |
| Blacks | 384 (59.8) | 176 (68.2) | 208 (54.2) | |
| Other | 23 (3.6) | 3 (1.2) | 20 (5.2) | |
| BMI (kg/m2), n (%) | <0.01 | |||
| Underweight | 20 (3.0) | 9 (3.4) | 11 (2.8) | |
| Normal | 229 (34.8) | 58 (21.8) | 171 (43.5) | |
| Overweight | 206 (31.3) | 87 (32.7) | 119 (32.8) | |
| Obesity | 204 (31.0) | 112 (42.1) | 92 (23.4) | |
| Median (IQR) | 26.9 (23.2, 31.4) | 28.5 (25.0, 33.6) | 25.5 (22.3, 29.9) | <0.01 |
| Cigarette smoking, n (%) | 0.28 | |||
| Never | 180 (28.8) | 75 (30.0) | 105 (28.0) | |
| Current | 330 (52.8) | 123 (49.2) | 207 (55.2) | |
| Former | 115 (18.4) | 52 (20.8) | 63 (16.8) | |
| Alcohol use, n (%) | 0.54 | |||
| Never drank any alcohol | 53 (8.8) | 24 (10.0) | 29 (8.1) | |
| No drinks in the past year | 129 (21.5) | 54 (22.6) | 75 (20.7) | |
| No heavy drinking in the past year | 365 (60.7) | 137 (57.3) | 228 (62.9) | |
| Heavy drinking in the past year | 54 (9.0) | 24 (10.1) | 30 (8.3) | |
| Antidepressant drugs in the past 6 months, n (%) | 0.01 | |||
| No | 390 (62.7) | 139 (55.8) | 251 (67.3) | |
| Yes and currently taking it | 183 (29.4) | 85 (34.1) | 98 (26.3) | |
| Yes but not taking it now | 49 (7.9) | 25 (10.1) | 24 (6.4) | |
| Any substance use in the past year, n (%) | 226 (40.7) | 104 (47.5) | 122 (36.2) | <0.01 |
| Diabetes, n (%) | 79 (12.0) | 59 (22.2) | 20 (5.1) | <0.01 |
| Renal Disease, n (%) | 75 (12.3) | 48 (19.7) | 27 (7.4) | <0.01 |
| Depression, n (%) | 189 (28.7) | 95 (35.7) | 94 (23.9) | <0.01 |
| Currently on ART, n (%) | 539 (81.8) | 216 (81.2) | 323 (82.2) | 0.75 |
| Nadir CD4 + T cell counts, cells/mm3, median (IQR) | 334 (146, 558) | 349 (160, 570) | 312 (141, 544) | 0.26 |
| Plasma viral load ≥ 200 copies/ml, n (%) | 173 (26.3) | 62 (23.3) | 111 (28.2) | 0.16 |
| CD4 + T cell counts ≥ 350 cells/mm3, n (%) | 464 (71.3) | 201 (75.9) | 263 (68.1) | 0.03 |
| Years of HIV Diagnosis, median (IQR) | 10 (4, 16) | 13 (7, 18) | 8 (3, 15) | <0.01 |
Note: ART: Antiretroviral Therapy; BMI: Body Mass Index; CI: Confidence Interval; IQR: Interquartile Range.